We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.08T
AUM Growth
+$79.9B
Cap. Flow
-$8.94B
Cap. Flow %
-0.83%
Top 10 Hldgs %
25.7%
Holding
3,000
New
159
Increased
1,164
Reduced
1,499
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.45B
2
PINS icon
Pinterest
PINS
+$1.89B
3
TMUS icon
T-Mobile US
TMUS
+$1.89B
4
ZM icon
Zoom
ZM
+$1.77B
5
PATH icon
UiPath
PATH
+$1.71B

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.66B
2
CAT icon
Caterpillar
CAT
+$1.32B
3
NFLX icon
Netflix
NFLX
+$1.18B
4
MXIM
Maxim Integrated Products
MXIM
+$1.15B
5
MU icon
Micron Technology
MU
+$1.07B

Sector Composition

Rank Sector Weight
1 Technology 24.62%
2 Healthcare 16.07%
3 Consumer Discretionary 15.29%
4 Communication Services 13.46%
5 Financials 12.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUBI icon
2501
Customers Bancorp
CUBI
$2.82B
$372K ﹤0.01%
9,540
+2,499
+35% +$90K
ESPR
2502
DELISTED
Esperion Therapeutics
ESPR
$371K ﹤0.01%
17,522
+480
+3% +$11.6K
VBIV
2503
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$370K ﹤0.01%
3,682
+79
+2% +$7.7K
PRPC.U
2504
DELISTED
CC Neuberger Principal Holdings III Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PRPC.U
$370K ﹤0.01%
37,054
+4,568
+14% +$46K
TR icon
2505
Tootsie Roll Industries
TR
$3.05B
$368K ﹤0.01%
+12,589
New +$355K
SUNW
2506
DELISTED
Sunworks, Inc.
SUNW
$368K ﹤0.01%
35,000
-5,200
-13% -$53.7K
BCOV
2507
DELISTED
Brightcove, Inc.
BCOV
$367K ﹤0.01%
25,566
+14,664
+135% +$235K
GOGO icon
2508
Gogo Inc
GOGO
$383M
$366K ﹤0.01%
32,161
+13,424
+72% +$155K
AIR icon
2509
AAR Corp
AIR
$5.86B
$364K ﹤0.01%
9,381
+607
+7% +$24.4K
CCLD icon
2510
CareCloud
CCLD
$104M
$363K ﹤0.01%
43,100
-16,500
-28% -$137K
TCS
2511
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$363K ﹤0.01%
1,858
+842
+83% +$175K
KGC icon
2512
Kinross Gold
KGC
$31.7B
$362K ﹤0.01%
57,037
-3,061,076
-98% -$22.7M
LAB icon
2513
Standard BioTools
LAB
$306M
$362K ﹤0.01%
58,842
+1,970
+3% +$10.5K
SRGA
2514
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$360K ﹤0.01%
8,640
+3,128
+57% +$160K
FCBC icon
2515
First Community Bankshares
FCBC
$932M
$359K ﹤0.01%
12,017
+1,631
+16% +$49.3K
SEI
2516
Solaris Energy Infrastructure
SEI
$4.06B
$359K ﹤0.01%
36,807
+626
+2% +$6.63K
ACR
2517
ACRES Commercial Realty
ACR
$102M
$358K ﹤0.01%
22,265
HY icon
2518
Hyster-Yale Materials Handling
HY
$622M
$357K ﹤0.01%
4,895
+826
+20% +$64.1K
VERI icon
2519
Veritone
VERI
$139M
$356K ﹤0.01%
18,087
+599
+3% +$13K
BCLI
2520
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$353K ﹤0.01%
6,200
-1,944
-24% -$104K
SCPL
2521
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$352K ﹤0.01%
20,741
+1,349
+7% +$23.2K
MGI
2522
DELISTED
MoneyGram International, Inc. New
MGI
$351K ﹤0.01%
34,778
-20,631
-37% -$174K
ANDE icon
2523
Andersons Inc
ANDE
$2.22B
$348K ﹤0.01%
11,410
+523
+5% +$15.8K
NNBR icon
2524
NN Inc
NNBR
$299M
$348K ﹤0.01%
47,357
-11,433
-19% -$85.9K
FOSL icon
2525
Fossil Group
FOSL
$334M
$347K ﹤0.01%
24,314
-11,568
-32% -$152K

Similar funds

T. Rowe Price Associates's Q2 2021 Portfolio in Review

As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
  • T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
  • T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
  • T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
  • T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
  • T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.

Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.